September 26, 2024
TOPLINE: Among patients with autoimmune hyperthyroidism, those who use cannabis are 1.9 times more likely to develop exophthalmos — eyes that appear to bulge from the […]
September 26, 2024
TOPLINE: Few federally qualified health centers (FQHCs) in Florida offer eye care services such as vision checks, prescriptions for glasses, and dilated eye exams, primarily provided […]
September 26, 2024
TOPLINE: Emapalumab (Gamifant)-containing regimens stabilize key laboratory parameters and show a high 12-month survival probability in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis (HLH). METHODOLOGY: Researchers conducted […]
September 26, 2024
TOPLINE: Apps designed to increase physical activity may be useful in increasing daily step counts for users who believe the intervention beneficial, but not for those […]
September 25, 2024
TOPLINE: Electronic health record (EHR)–derived family history identified 29,913 patients with familial risk for hereditary breast and ovarian cancer, but 82% had no evidence of genetic […]
September 25, 2024
TOPLINE: Treatment-resistant major depression (TRD) is associated with a 17% higher risk for all-cause mortality than non-TRD major depressive disorder (MDD), a new study shows. The […]
September 25, 2024
TOPLINE: Menopausal hormone therapy (MHT) is associated with a 16% lower risk for psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD), especially in women […]
September 25, 2024
TOPLINE: Survival rates for patients with hepatocellular carcinoma (HCC) have improved, but overall survival remains low. Early detection and treatment significantly enhanced survival outcomes between January […]
September 25, 2024
TOPLINE: The prevalence of diabetes in the United States increased by 18.6% from 2012 to 2022, with notably higher rates among racial and ethnic minorities, men, […]